247 related articles for article (PubMed ID: 32891000)
21. A sucrose-binding site provides a lead towards an isoform-specific inhibitor of the cancer-associated enzyme carbonic anhydrase IX.
Pinard MA; Aggarwal M; Mahon BP; Tu C; McKenna R
Acta Crystallogr F Struct Biol Commun; 2015 Oct; 71(Pt 10):1352-8. PubMed ID: 26457530
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and biological activity studies of carbonic anhydrase inhibitors.
Erzurum D; Osmaniye D; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Z Naturforsch C J Biosci; 2023 Nov; 78(11-12):421-432. PubMed ID: 37924267
[TBL] [Abstract][Full Text] [Related]
23. Discovery of indolinone-bearing benzenesulfonamides as new dual carbonic anhydrase and VEGFR-2 inhibitors possessing anticancer and pro-apoptotic properties.
Saied S; Shaldam M; Elbadawi MM; Giovannuzzi S; Nocentini A; Almahli H; Salem R; Ibrahim TM; Supuran CT; Eldehna WM
Eur J Med Chem; 2023 Nov; 259():115707. PubMed ID: 37556946
[TBL] [Abstract][Full Text] [Related]
24. A potentiated cooperation of carbonic anhydrase IX and histone deacetylase inhibitors against cancer.
Ruzzolini J; Laurenzana A; Andreucci E; Peppicelli S; Bianchini F; Carta F; Supuran CT; Romanelli MN; Nediani C; Calorini L
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):391-397. PubMed ID: 31865754
[TBL] [Abstract][Full Text] [Related]
25. Targeting carbonic anhydrases for the management of hypoxic metastatic tumors.
Supuran CT
Expert Opin Ther Pat; 2023 Nov; 33(11):701-720. PubMed ID: 37545058
[TBL] [Abstract][Full Text] [Related]
26. Identification of thienopyrimidine derivatives tethered with sulfonamide and other moieties as carbonic anhydrase inhibitors: Design, synthesis and anti-proliferative activity.
Higazy S; Samir N; El-Khouly A; Giovannuzzi S; Begines P; Gaber HM; Supuran CT; Abouzid KAM
Bioorg Chem; 2024 Mar; 144():107089. PubMed ID: 38237393
[TBL] [Abstract][Full Text] [Related]
27. Novel sulfonamide-phosphonate conjugates as carbonic anhydrase isozymes inhibitors.
Bekheit MS; Sabry E; Mohamed HA; Ewies EF; Kariuki BM; Fouad MA; Vullo D; Supuran CT
Drug Dev Res; 2024 Feb; 85(1):e22135. PubMed ID: 37997034
[TBL] [Abstract][Full Text] [Related]
28. Switching the Inhibitor-Enzyme Recognition Profile via Chimeric Carbonic Anhydrase XII.
Smirnovienė J; Smirnov A; Zakšauskas A; Zubrienė A; Petrauskas V; Mickevičiūtė A; Michailovienė V; Čapkauskaitė E; Manakova E; Gražulis S; Baranauskienė L; Chen WY; Ladbury JE; Matulis D
ChemistryOpen; 2021 May; 10(5):567-580. PubMed ID: 33945229
[TBL] [Abstract][Full Text] [Related]
29. A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments.
Hefny SM; El-Moselhy TF; El-Din N; Ammara A; Angeli A; Ferraroni M; El-Dessouki AM; Shaldam MA; Yahya G; Al-Karmalawy AA; Supuran CT; Tawfik HO
Eur J Med Chem; 2024 Aug; 274():116527. PubMed ID: 38810335
[TBL] [Abstract][Full Text] [Related]
30. Novel benzene sulfonamides with acetylcholinesterase and carbonic anhydrase inhibitory actions.
El Ati R; Öztaşkın N; Çağan A; Akıncıoğlu A; Demir Y; Göksu S; Touzani R; Gülçin İ
Arch Pharm (Weinheim); 2024 Jun; 357(6):e2300545. PubMed ID: 38423951
[TBL] [Abstract][Full Text] [Related]
31. Insights towards sulfonamide drug specificity in α-carbonic anhydrases.
Aggarwal M; Kondeti B; McKenna R
Bioorg Med Chem; 2013 Mar; 21(6):1526-33. PubMed ID: 22985956
[TBL] [Abstract][Full Text] [Related]
32. Inhibitor binding to metal-substituted metalloenzyme: Sulfonamide affinity for carbonic anhydrase IX.
Baronas D; Knašienė B; Mickevičiūtė A; Jachno J; Naujalis E; Zubrienė A; Matulis D
J Inorg Biochem; 2024 Jul; 256():112547. PubMed ID: 38581802
[TBL] [Abstract][Full Text] [Related]
33. Keto-bridged dual triazole-linked benzenesulfonamides as potent carbonic anhydrase and cathepsin B inhibitors.
Vats L; Arya P; Kumar R; Giovannuzzi S; Raghav N; Supuran CT; Sharma PK
Future Med Chem; 2023 Oct; 15(20):1843-1863. PubMed ID: 37877291
[No Abstract] [Full Text] [Related]
34. Identification of 3-(5-cyano-6-oxo-pyridin-2-yl)benzenesulfonamides as novel anticancer agents endowed with EGFR inhibitory activity.
Shaldam MA; Khalil AF; Almahli H; Jaballah MY; Angeli A; Khaleel EF; Badi RM; Elkaeed EB; Supuran CT; Eldehna WM; Tawfik HO
Arch Pharm (Weinheim); 2024 Jan; 357(1):e2300449. PubMed ID: 37828544
[TBL] [Abstract][Full Text] [Related]
35. Assessment of the antiproliferative and apoptotic roles of sulfonamide carbonic anhydrase IX inhibitors in HeLa cancer cell line.
Koyuncu I; Gonel A; Durgun M; Kocyigit A; Yuksekdag O; Supuran CT
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):75-86. PubMed ID: 30362386
[TBL] [Abstract][Full Text] [Related]
36. Synthetic Approaches to Novel Human Carbonic Anhydrase Isoform Inhibitors Based on Pyrrol-2-one Moiety.
Al-Matarneh CM; Pinteala M; Nicolescu A; Silion M; Mocci F; Puf R; Angeli A; Ferraroni M; Supuran CT; Zara S; Carradori S; Paoletti N; Bonardi A; Gratteri P
J Med Chem; 2024 Feb; 67(4):3018-3038. PubMed ID: 38301036
[TBL] [Abstract][Full Text] [Related]
37. 1,5-Diaryl-1,2,4-triazole Ureas as New SLC-0111 Analogues Endowed with Dual Carbonic Anhydrase and VEGFR-2 Inhibitory Activities.
Elsawi AE; Elbadawi MM; Nocentini A; Almahli H; Giovannuzzi S; Shaldam M; Salem R; Ibrahim TM; Abdel-Aziz HA; Supuran CT; Eldehna WM
J Med Chem; 2023 Aug; 66(15):10558-10578. PubMed ID: 37501287
[TBL] [Abstract][Full Text] [Related]
38. Targeting carbonic anhydrase IX activity and expression.
Mahon BP; Pinard MA; McKenna R
Molecules; 2015 Jan; 20(2):2323-48. PubMed ID: 25647573
[TBL] [Abstract][Full Text] [Related]
39. Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma.
Tawfik HO; Saleh MM; Ammara A; Khaleel EF; Badi R; Khater YTT; Rasheed RA; Attia AA; Hefny SM; Elkaeed EB; Nocentini A; Supuran CT; Eldehna WM; Shaldam MA
J Med Chem; 2024 Jan; 67(2):1611-1623. PubMed ID: 38207099
[TBL] [Abstract][Full Text] [Related]
40. Design, synthesis and mechanism study of coumarin-sulfonamide derivatives as carbonic anhydrase IX inhibitors with anticancer activity.
Lv Q; Zhang J; Cai J; Chen L; Liang J; Zhang T; Lin J; Chen R; Zhang Z; Guo P; Hong Y; Pan L; Ji H
Chem Biol Interact; 2024 Apr; 393():110947. PubMed ID: 38479716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
